medtech

Views & Analysis

Meeting public expectations of diagnostics is the next big t...

Ivor Campbell looks at the way the UK medtech sector has responded to COVID-19 and the implications of more advanced diagnostics for prescribing and general practice.

Views & Analysis

Accelerating digital engagement in medtech

Agnitio’s CEO Lars Diemer speaks with senior medtech execs every week.

News

Orphan drugs dominate 2018 UK Prix Galien shortlist

A bumper crop of orphan drugs from the likes of Amicus, Kyowa Kirin, Eusa and Biogen dominates this year’s UK Prix Galien shortlist as biotech firms and specialist pharma companies cement t

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

How to make digital work in medtech

Overview The rise of mobile devices and apps, not to mention the involvement of non-medical technology players, is creating a wave of irrevocable digital change for medtech.

Views & Analysis

Brexit Health Alliance warns on infection threat

Medtech is key in fight against AMR

Paul Chapman examines the challenge of antimicrobial resistance (AMR) and how it could be beaten.

Views & Analysis

Navigating the regulatory pathway with innovative products

Start-ups in the medtech space face many challenges on the way to market, not the least of which is how to prepare for, and comply with, medical device regulations.

Meeting public expectations of diagnostics is the next big t...

Accelerating digital engagement in medtech

Orphan drugs dominate 2018 UK Prix Galien shortlist

How to make digital work in medtech

Medtech is key in fight against AMR

Navigating the regulatory pathway with innovative products

CDMOs: Their crucial role and how to select one, with Sigma ...

How to meet your physicians where they are online

medtech

Editor's Picks